Edition:
United States

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

4.20USD
15 Jun 2018
Change (% chg)

$-0.05 (-1.18%)
Prev Close
$4.25
Open
$4.20
Day's High
$4.25
Day's Low
$4.03
Volume
21,095
Avg. Vol
36,844
52-wk High
$9.80
52-wk Low
$4.03

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 240.92 34.18
P/E High - Last 5 Yrs. -- 292.40 47.65
P/E Low - Last 5 Yrs. -- 101.52 25.16
Beta -- 0.73 0.78
Price to Sales (TTM) -- 277.70 8.57
Price to Book (MRQ) -- 23.83 4.35
Price to Tangible Book (MRQ) -- 31.28 6.03
Price to Cash Flow (TTM) -- 141.17 22.78
% Owned Institutions -- 10.77 2.40

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.24 -6.56
Payout Ratio(TTM) -- 42.16 39.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 24.66 5.00
Sales (TTM) vs TTM 1 Yr. Ago -- 138.03 12.50
Sales - 5 Yr. Growth Rate -- 30.82 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -77.30 40.63
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 48.49 8.03
Capital Spending - 5 Yr. Growth Rate -- 36.28 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.56
Current Ratio (MRQ) -- 6.39 3.64
LT Debt to Equity (MRQ) -- 20.82 12.92
Total Debt to Equity (MRQ) -- 25.11 17.37
Interest Coverage (TTM) -- -142.62 35.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.39 54.96
Gross Margin - 5 Yr. Avg. -- 54.91 52.86
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -171.18 15.70
Operating Margin (TTM) -- -947.86 -0.76
Operating Margin - 5 Yr. Avg. -- -184.89 10.94
Pre-Tax Margin (TTM) -- -831.06 1.32
Pre-Tax Margin - 5 Yr. Avg. -- -188.29 11.12
Net Profit Margin (TTM) -- -824.15 -1.97
Net Profit Margin - 5 Yr. Avg. -- -186.71 7.48
Effective Tax Rate (TTM) -- 15.20 29.90
Effective Tax Rate - 5 Yr. Avg. -- 19.22 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,950,230 736,829,609
Net Income/Employee (TTM) -- -523,802 85,814,668
Receivable Turnover (TTM) -- 18.22 6.06
Inventory Turnover (TTM) -- 2.86 3.65
Asset Turnover (TTM) -- 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -3.98 10.37
Return on Assets - 5 Yr. Avg. -- -1.14 11.09
Return on Investment (TTM) -- -5.87 13.17
Return on Investment - 5 Yr. Avg. -- 1.58 14.39
Return on Equity (TTM) -- -7.71 15.15
Return on Equity - 5 Yr. Avg. -- -3.84 15.73
Note: Units in Millions of US Dollars

Performance for Intec Pharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.